Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
146,614,676
-
Total 13F shares
-
190,372,465
-
Share change
-
-8,532,515
-
Total reported value
-
$58,410,852,053
-
Put/Call ratio
-
145%
-
Price per share
-
$306.35
-
Number of holders
-
960
-
Value change
-
-$2,559,309,169
-
Number of buys
-
419
-
Number of sells
-
437
Institutional Holders of BIOGEN INC. - COM (BIIB) as of Q4 2015
As of 31 Dec 2015,
BIOGEN INC. - COM (BIIB) was held by
960 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
190,372,465 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, VANGUARD GROUP INC, FMR LLC, STATE STREET CORP, Clearbridge Investments, LLC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Institutional Trust Company, N.A., WELLINGTON MANAGEMENT GROUP LLP, BlackRock Fund Advisors, and JPMORGAN CHASE & CO.
This page lists
961
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.